Trained immunity-primed DLL3-targeted CAR macrophages for the eradication of small cell lung cancer
{{output}}
Background: Small cell lung cancer (SCLC) is highly malignant with limited treatment options. Chimeric antigen receptor macrophages (CAR-Ms) show potential for solid tumor therapy due to their phagocytic activity, tissue penetrat... ...
